Category: Featured Content
-
Pure Extracts (PULL.C) cuts a licensing deal with Taste-T, the maker of Fireball Cannabis Gummies
Included in the agreement is the delivery to Pure Extracts’ British Columbia facility of one of Taste-T’s custom built gummie-manufacturing machines, certified to Canadian standards.
-
Organic Garage (OG.V) shifts from regional specialty grocer to plant-based foods player – and 10x’s
It’s no secret plant-based foods have been one of the real go-to investor categories of the rampaging North American stock market over the last year, especially since Beyond Meat (BYND.Q) went public in the US in late 2019 and went on an insane run, eventually settling in as a $10 billion company. It started a…
-
Flashing sell signal!! Did this grotesque pitchman just apply the KISS of death to dogecoin?
“Smart Money is capital that is being controlled by institutional investors, market mavens, central banks, funds, and other financial professionals,” states Investopedia, “Cash invested by well informed investors is considered to have a better chance of success.” At a gut-level, following “Smart Money” is seductive. If you invested in a shopping mall, and were then invited…
-
Diagnos (ADK.V) A.I. retina analysis creates a powerful early warning system for diabetics
DIAGNOS specialises in early detection of health problems based on its FLAIRE artificial intelligence (AI) platform.
-
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…
-
Medexus Pharmaceuticals (MDP.V), Flexing its deal making muscles
Buckle up everyone, and get excited – let’s break down Medexus’ latest press release with all its technical details. This is a two-parter, because Medexus not only has closed an important deal that has relevancy for blood cancer treatments, but it’s also upsized its current financing – a financial move that’s indicative of the growing…